Minnesota’s share of a $71 million multistate settlement with biotech drugmaker Amgen tops $1.2 million. The deal to end an investigation into illegal marketing of two drugs made by the company was announced earlier this week. Court papers filed in Minnesota say the state’s portion will go toward individuals who experienced harm, administrative costs and the general treasury if any is left.
It seems the two go hand-in-hand: chemotherapy and losing your hair. However, some cancer patients are keeping their hair in the midst of aggressive treatments: It’s called cold cap therapy.